High CDC20 levels increase sensitivity of cancer cells to MPS1 inhibitors

Siqi Zheng1, Linoy Raz2, Lin Zhou1

  • 1European Research Institute for the Biology of Ageing, University of Groningen, 1, Antonius Deusinglaan, 9713 AV, Groningen, The Netherlands.

EMBO Reports
|January 21, 2025
PubMed

Insights

Spindle assembly checkpoint (SAC) inhibitors are sensitive to high CDC20 expression. This sensitivity is linked to aneuploidy, a cellular vulnerability that shortens metaphase and increases mitotic errors, enhancing drug efficacy.

Area of Science:

  • Cell Biology
  • Cancer Therapeutics
  • Molecular Oncology

Background:

  • Spindle assembly checkpoint (SAC) inhibitors are novel drugs that disrupt chromosome segregation, leading to chromosomal instability (CIN) and cell death.
  • The precise molecular determinants of cellular sensitivity to SAC inhibitors remain unclear.
  • Previous research indicated that aneuploid cancer cells exhibit heightened sensitivity to SAC inhibition.

Purpose of the Study:

  • To investigate the molecular drivers of sensitivity to SAC inhibition, particularly by MPS1 inhibitors.
  • To elucidate the role of CDC20, a key activator of the anaphase-promoting complex (APC/C), in mediating cellular responses to SAC inhibitors.
  • To explore the relationship between aneuploidy, CDC20 expression, and sensitivity to SAC inhibition therapy.

Main Methods:

  • Investigated the impact of CDC20 expression levels on cellular sensitivity to SAC inhibitors.
  • Utilized MPS1 inhibitors as a model for SAC inhibition.
  • Analyzed metaphase duration, mitotic error rates, and CIN induction in response to CDC20 modulation and SAC inhibition.
  • Compared CDC20 expression and SAC inhibitor sensitivity in aneuploid versus euploid cancer cells.

Main Results:

  • Sensitivity to MPS1 inhibitors is predominantly determined by CDC20 expression, with a greater effect than APC/C itself.
  • Depletion of CDC20 prolongs metaphase, reduces mitotic errors, and decreases sensitivity to SAC inhibition.
  • Aneuploid cells exhibit higher basal CDC20 levels, leading to shorter metaphase durations and increased susceptibility to SAC inhibitor-induced CIN.

Conclusions:

  • High CDC20 expression is a key molecular feature predicting sensitivity to SAC inhibition therapy.
  • Aneuploidy-induced elevation of CDC20 creates a cellular vulnerability that enhances the efficacy of SAC inhibitors.
  • Findings suggest CDC20 as a potential biomarker for patient stratification in SAC inhibitor-based cancer treatments.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K